If a machine counts the cells in a tube of blood, what does a medical laboratory scientist do? One answer is that the scientist decides whether the sample and the numbers can be trusted. Take a routine complete blood count, or CBC. It reports information about red blood cells, white blood cells, and platelets, as well as measurements such as hemoglobin. Before those results reach the care team, the lab needs to know that the tube belongs to the right patient, that the instrument is working as expected, and that any unusual findings have been handled.
When the tube arrives, lab staff match the identifiers on its label to the test order and log it in the laboratory information system. They also check whether the tube is suitable for the test. A CBC is generally run on whole blood collected in a tube containing EDTA, a substance that prevents clotting. The blood cells need to stay in the sample rather than get trapped in a clot.
Suppose the tube appears to contain enough blood but has a visible clot. Running it anyway could produce a misleading count because the cells in the clot are not evenly represented in the blood the instrument samples. The scientist follows the lab's rejection policy and may ask the care team for a new specimen. That can mean another needle stick and a delay, but reporting a number from an unsuitable sample can lead to decisions based on a result that does not reflect the patient's blood.
A label mismatch poses a different problem. Even a perfectly measured result is unsafe if it goes into the wrong patient's record. A barcode helps staff track the tube, but it does not remove the need to resolve an identification problem according to lab policy.
Before reporting patient results, the lab checks the analyzer with quality control materials that have expected ranges for the measurements. If a control falls outside the lab's acceptable limits, the scientist investigates according to procedure. The issue might be with the control material, a reagent, or the instrument itself. The scientist holds affected results until the problem is resolved rather than assuming an ordinary-looking patient result must be right.
Once the instrument is ready and the tube has been accepted, the blood is mixed so that the portion drawn into the analyzer represents the contents of the tube. The analyzer measures properties of the cells to count and classify them. Different instruments do this in different ways. Some, for example, detect changes in an electrical signal as cells pass through a small opening. The machine processes cells much faster than a person could count them under a microscope, but it can also flag a result it cannot classify confidently.
Suppose the analyzer reports a low platelet count and flags possible platelet clumps. Platelets help stop bleeding, so a low count can matter to the care team. But if platelets stick together in the tube, the analyzer may not count them individually. The question is whether the reported number reflects the blood in the patient or something that happened in the specimen.
Under the lab's review rules, the scientist may examine a blood smear, a thin layer of blood spread on a glass slide and stained so its cells can be seen clearly. If clumps are visible, repeating the test on the same tube may not solve the problem. Depending on the procedure, the lab may request a new sample collected in a tube with a different anticoagulant. Finding clumps does not, by itself, establish that the patient's platelet count is normal. It tells the scientist not to treat the original number as reliable without further work.
Not every CBC needs a microscope review. A laboratory can use validated software rules to release results automatically when the required checks pass. When a result needs manual review, the scientist may look at instrument flags, specimen quality, and earlier results if available. A result that meets the lab's criteria for a critical value also calls for prompt communication to the care team under the lab's policy. A verified result can still be abnormal: verification means the result has passed the applicable checks, not that the patient is healthy. MedlinePlus explains what a CBC measures and how the results fit into patient care.
For practice connecting science with medical reasoning, see the IMedC learning resources. The Studies and Careers articles can help you compare laboratory work with other health careers.
Job titles, approved training programs, and requirements for certification or registration vary by country and sometimes by region. In the United States, the Bureau of Labor Statistics profile for clinical laboratory technologists and technicians describes a bachelor's degree as the typical entry-level education for technologists and notes that some states require licensure. That example is not a rule for other countries, and jobs with similar titles can have different scopes of practice.
When comparing programs, start with the professional regulator or credentialing body where you want to work. Check whether a program is recognized, what supervised clinical experience it includes, and whether finishing it makes you eligible for any required exam or registration. Ask the program where students complete clinical placements and whether they get supervised practice reviewing flagged results, not just running instruments.
Does every blood count get checked under a microscope?
No. Many results pass automated checks, while certain flags or unusual findings can trigger a smear review under the lab's rules.
Does a verified result mean my blood count is normal?
No. It means the result passed the applicable laboratory checks. Your care team interprets the result in the context of your health.
Do I need the same qualifications in every country?
No. Check the approved training and credential requirements where you plan to work, since job titles and rules can differ.
About the International Medicine Competition: an online medicine competition for high school students from around the world. Qualification Round 2027: submissions are open until Sunday, 7 February 2027. How the rounds work